Distinct Antibody Responses to Endemic Coronaviruses Pre- and Post-SARS-CoV-2 Infection in Kenyan Infants and Mothers.
Distinct Antibody Responses to Endemic Coronaviruses Pre- and Post-SARS-CoV-2 Infection in Kenyan Infants and Mothers.
复制标题
DOI:
10.3390/v14071517
复制
发表时间:
2022-07-12
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Pre-existing antibodies that bind endemic human coronaviruses (eHCoVs) can cross-react with SARS-CoV-2, which is the betacoronavirus that causes COVID-19, but whether these responses influence SARS-CoV-2 infection is still under investigation and is particularly understudied in infants. In this study, we measured eHCoV and SARS-CoV-1 IgG antibody titers before and after SARS-CoV-2 seroconversion in a cohort of Kenyan women and their infants. Pre-existing eHCoV antibody binding titers were not consistently associated with SARS-CoV-2 seroconversion in infants or mothers; however, we observed a very modest association between pre-existing HCoV-229E antibody levels and a lack of SARS-CoV-2 seroconversion in the infants. After seroconversion to SARS-CoV-2, antibody binding titers to the endemic betacoronaviruses HCoV-OC43 and HCoV-HKU1, and the highly pathogenic betacoronavirus SARS-CoV-1, but not the endemic alphacoronaviruses HCoV-229E and HCoV-NL63, increased in the mothers. However, eHCoV antibody levels did not increase following SARS-CoV-2 seroconversion in the infants, suggesting the increase seen in the mothers was not simply due to cross-reactivity to naively generated SARS-CoV-2 antibodies. In contrast, the levels of antibodies that could bind SARS-CoV-1 increased after SARS-CoV-2 seroconversion in both the mothers and infants, both of whom were unlikely to have had a prior SARS-CoV-1 infection, supporting prior findings that SARS-CoV-2 responses cross-react with SARS-CoV-1. In summary, we found evidence of increased eHCoV antibody levels following SARS-CoV-2 seroconversion in the mothers but not the infants, suggesting eHCoV responses can be boosted by SARS-CoV-2 infection when a prior memory response has been established, and that pre-existing cross-reactive antibodies are not strongly associated with SARS-CoV-2 infection risk in mothers or infants.
登录
查看更多内容
影响因子:
3.7
作者:
Bonhomme ME;Bonhomme CJ;Strelow L;Chaudhari A;Howlett A;Breidenbach C;Hester J;Hammond C;Fuzy M;Harvey L;Swanner V;Ellis J;Greway RR;Pisciella VA;Green T;Kierstead L
通讯作者:
Kierstead L
影响因子:
30.3
作者:
Lin CY;Wolf J;Brice DC;Sun Y;Locke M;Cherry S;Castellaw AH;Wehenkel M;Crawford JC;Zarnitsyna VI;Duque D;Allison KJ;Allen EK;Brown SA;Mandarano AH;Estepp JH;SJTRC Study Team;Taylor C;Molina-Paris C;Schultz-Cherry S;Tang L;Thomas PG;McGargill MA
通讯作者:
McGargill MA
影响因子:
82.9
作者:
通讯作者:
--
DOI:
10.1093/infdis/jiaa691
发表时间:
2021-02-13
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
Goldstein E;Lipsitch M;Cevik M
通讯作者:
Cevik M
DOI:
10.1016/j.ijid.2020.10.104
发表时间:
2021-01
期刊:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
影响因子:
--
作者:
Tso FY;Lidenge SJ;Peña PB;Clegg AA;Ngowi JR;Mwaiselage J;Ngalamika O;Julius P;West JT;Wood C
通讯作者:
Wood C